South Africa's Saltzman Family Sees 28.6 Million Gain From Dis-chem Shares

Saltzman family stake in Dis-Chem rises to 476 million after shares gain 6.4 in just 22 days on the Johannesburg Stock Exchange.

Dis-Chem shares rise 6.4 since May 8, lifting the companys market cap to over 1.6 billion and delivering solid gains to major investors.

Despite recent gains, Dis-Chem shares are down 6.57 in 2025, with a 100,000 investment declining to 93,430, reflecting lingering market pressures.

The Saltzman familyamong South Africas wealthiesthas recorded a significant boost in the market value of their stake in Dis-Chem Pharmacies, following a sharp rise in the companys share price on the Johannesburg Stock Exchange JSE .

Lynette and Ivan Saltzman, the founders of Gauteng-based healthcare giant Dis-Chem, along with their family, own a 29.3 percent stake in the companyamounting to 252,066,319 shares.

In the past 22 days alone, the market value of the familys stake has risen by R511.69 million 28.63 million, bringing their total holding to 476 million. This increase highlights the family's position as one of South Africas wealthiest.

This recent gain follows an earlier rise in their stakes value, which grew by 53.5 million between Apr. 4 and May 5 . During that period, their holdings climbed from R7.08 billion 387.44 million to R9.17 billion 515.9 million, highlighting the steady strength of their investment in Dis-Chem.

Founded more than four decades ago, Dis-Chem has grown into one of South Africas leading names in retail healthcare. The company operates dispensaries, family clinics, wound care centers, and large self-medication hubs, cementing its role as a vital part of everyday healthcare for many South Africans.